Research Papers:

PIG7 promotes leukemia cell chemosensitivity via lysosomal membrane permeabilization

Jiazhuo Liu, Leiwen Peng, Ting Niu, Yu Wu, Jianjun Li, Fangfang Wang, Yuhuan Zheng and Ting Liu _

PDF  |  HTML  |  How to cite  |  Order a Reprint

Oncotarget. 2016; 7:4841-4859. https://doi.org/10.18632/oncotarget.6739

Metrics: PDF 1259 views  |   HTML 1349 views  |   ?  


Jiazhuo Liu1,*, Leiwen Peng2,*, Ting Niu1, Yu Wu1, Jianjun Li1, Fangfang Wang1, Yuhuan Zheng1, Ting Liu1

1Department of Hematology, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China

2Department of Laboratory Medicine, West China Second University Hospital, Sichuan University, Chengdu, Sichuan 610041, China

*These authors contributed equally to this work

Correspondence to:

Ting Liu, email: liuting@scu.edu.cn

Yuhuan Zheng, email: yuhuan_zheng@163.com

Keywords: PIG7, LMP, chemosensitivity, cathepsin, ROS

Received: July 08, 2015     Accepted: November 30, 2015     Published: December 23, 2015


PIG7 localizes to lysosomal membrane in leukemia cells. Our previous work has shown that transduction of pig7 into a series of leukemia cell lines did not result in either apoptosis or differentiation of most tested cell lines. Interestingly, it did significantly sensitize these cell lines to chemotherapeutic drugs. Here, we further investigated the mechanism underlying pig7-induced improved sensitivity of acute leukemia cells to chemotherapy. Our results demonstrated that the sensitization effect driven by exogenous pig7 was more effective in drug-resistant leukemia cell lines which had lower endogenous pig7 expression. Overexpression of pig7 did not directly activate the caspase apoptotic pathway, but decreased the lysosomal stability. The expression of pig7 resulted in lysosomal membrane permeabilization (LMP) and lysosomal protease (e.g. cathepsin B, D, L) release. Moreover, we also observed increased reactive oxygen species (ROS) and decreased mitochondrial membrane potential (ΔΨm) induced by pig7. Some autophagy markers such as LC3I/II, ATG5 and Beclin-1, and necroptosis maker MLKL were also stimulated. However, intrinsic antagonism such as serine/cysteine protease inhibitors Spi2A and Cystatin C prevented downstream effectors from triggering leukemia cells, which were only on the “verge of apoptosis”. When combined with chemotherapy, LMP increased and more proteases were released. Once this process was beyond the limit of intrinsic antagonism, it induced programmed cell death cooperatively via caspase-independent and caspase-dependent pathways.

Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.
PII: 6739